Summary
The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode)
study is a prospective, observational multi-site study without randomization. The primary
objective of the study is to evaluate the performance characteristics of a blood-based ctDNA
LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.